OVArian cancer Non-Interventional Study - OVATAR - OVATAR

Study identifier:NIS-ORU-XXX-2014/1

ClinicalTrials.gov identifier:NCT02122588

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

OVArian cancer Non-Interventional Study. Treatment hAbits and epidemiology of BRCA in Russian Federation - OVATAR

Medical condition

Ovarian, peritoneal, fallopian tube cancer, BRCAm+ in Russia

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

Female

Actual Enrollment

503

Study type

Observational

Age

N/A

Date

Study Start Date: 30 Jun 2014
Primary Completion Date: 31 May 2018
Study Completion Date: 31 May 2018

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2019 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

RUSSCO (Russian Society of Clinical Oncology)

Inclusion and exclusion criteria